SCHEMBL845089

SCHEMBL845089

Cc1ccoc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3occc3C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
ALDH1A1 P00352 3/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
EPHX2 P34913 2/20 0.43
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NPC1 O15118 1/20 0.43
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845008 0.81 ALDH1A1 (0.54) TSHRALDH1A1CYP2C9CYP2C19NPSR1
SCHEMBL845182 0.81 HSD17B10 (0.57) ALDH1A1CYP2C9CYP2C19RHOCRHOA
SCHEMBL845592 0.79 KMT2A (0.64) TSHRALDH1A1CYP2C9CYP2C19NPSR1
SCHEMBL873200 0.78 RHOC (0.48) ALDH1A1CYP2C9CYP2C19RHOCRHOA
SCHEMBL845403 0.78 GFER (0.46) TSHRALDH1A1CYP2C9CYP2C19RHOC
SCHEMBL845300 0.78 CYP2C9 (0.54) ALDH1A1CYP2C9CYP2C19RHOCRHOA
SCHEMBL845697 0.77 ALDH1A1 (0.45) TSHRALDH1A1CYP2C9CYP2C19RHOC
SCHEMBL845421 0.77 ALDH1A1 (0.42) TSHRALDH1A1CYP2C9CYP2C19RHOC
SCHEMBL845258 0.77 MAPK1 (0.60) TSHRALDH1A1CYP2C9CYP2C19NPSR1
SCHEMBL845338 0.77 RHOC (0.48) TSHRALDH1A1CYP2C9CYP2C19RHOC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed